NEW YORK--(BUSINESS WIRE)-- VB Spine LLC (“VB Spine”), a global, family-owned spine company, today announced that it has entered a partnership to fund research of molecular genetics affecting pediatric scoliosis. The research will be conducted by Dr. Alain Moreau of the Centre de recherche Azrieli du CHU Sainte-Justine, Montreal, Canada.

“VB Spine’s mission is specifically centered around the patient: Everything starts with the patient, inspiring us to redefine spine care,” said Marc Viscogliosi, co-CEO of VB Spine, speaking on behalf of his brothers and fellow co-CEOs Anthony and John Viscogliosi. “The trailblazing research that Dr. Moreau is conducting brings that mission to life by allowing doctors the ability to intervene earlier in a patient’s journey and greatly reducing the need for critical care later in life.”

VB Spine Funds Landmark Research to Deliver the First Predictive Blood Test for Scoliosis in Adolescents

Business Wire